Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Boston University and Fraunhofer Create Alliance

By Labmedica staff writers
Posted on 30 Nov 2006
Boston University (BU, Boston, MA, USA) and its College of Engineering are joining Fraunhofer Gesellschaft (Munich, Germany) to create the Boston University-Fraunhofer Alliance for Medical Devices, Instrumentation and Diagnostics. More...
BU and Fraunhofer will jointly fund the five-year, U.S.$5 million alliance, which aims to develop arrays for diagnostic applications.

Andrew Sharon, a BU engineering professor and director of the Fraunhofer Center for Manufacturing and Innovation, said that the alliance will create disposable chips for molecular-level disease diagnosis. The firm will fabricate DNA and peptide arrays and perform translational research with the medical school. An optically guided colon-cancer detection and treatment system is a promising innovation also under consideration for initial support by the alliance.

The alliance seeks to take advantage of the two institutions' respective strengths. Advanced biomedical engineering research being conducted throughout BU's College of Engineering, College of Arts and Sciences, and Medical School, generally proceeds to the laboratory bench level. Fraunhofer hopes to take these innovations and convert them into working medical devices and instruments that can be licensed to existing companies or new, spin-off ventures.

Fraunhofer Gesellschaft is very active in biomedical research. Current activities include array-based diagnostics, medical imaging, surgical micro-tools development, and other novel devices and instrumentation. The Fraunhofer Center for Manufacturing Innovation was established at Boston University in 1994. The center scales up basic research into advanced industrial technologies that meet the needs of client companies both locally and globally.



Related Links:
Boston University
Fraunhofer Gesellschaft

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Gastrointestinal Panel
Xpert® GI Panel
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A simple daily blood test could help critically ill sepsis patients stop antibiotics sooner, reducing overuse and potentially helping combat antibiotic resistance (Image Credit: Adobe Stock)

Daily Blood Biomarker Testing May Help Guide Earlier Antibiotic Stopping in Sepsis

Sepsis is a life-threatening condition caused by the body’s overwhelming response to infection and accounts for thousands of deaths each year. In intensive care, concern about stopping treatment too early... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.